Bioxyne Share Price and Company Fundamentals



Price
$0.025
Change
0.001 (4.167%)
52 week
0.011 - 0.036

Last traded: Today at 4:36 AM

Bioxyne Limited, a life sciences and health products company, engages in the research and development, manufacture, and distribution of probiotic active pharmaceutical ingredients, wellbeing and nutritional supplements, and beauty products. The company operates in two segments, Wholesale Sales and Direct Sales. It engages in developing various functional foods and beauty products. The company's products portfolio includes Progastrim PCC, a proprietary probiotic, for general health and immune support; Mymana and ColosNZ, are colostrum and fortified milks for nutrition and immune support; BK18, a dairy based formula with probiotics and vitamins; Allura, a weight management and beauty drink for women; Mustang, a weight management and vitality shake for men; and BEssence, offers beauty range products comprising anti-ageing serum. Bioxyne Limited also offers foaming and toning cleanser, repair oils, and Progastrim, a probiotic dietary supplement for gut and immune health. The company provides its products online, as well as through wholesale and direct sales in Australia, the United States, New Zealand, and Asia. Bioxyne Limited was incorporated in 1998 and is headquartered in Sydney, Australia.

Key Metrics

PE ratio

-

PB ratio

9.19

Dividend yield

Beta

1.25

Market cap

-

Enterprise value

-

Company profile

Primary activitiesBiotechnology.
Industry / SectorBiotechnology / Healthcare
Websitehttps://www.bioxyne.com
Mailing address50 Clarence Street Suite 506 Level 5 Sydney NSW 2000 Australia
Phone / Fax61 2 9078 8180 / 61 2 9078 7661
Share registryAUTOMIC REGISTRY SERVICES

Dividends

Bioxyne does not pay dividends.

Company Executives

As of Jan 2022, following are the company executives and directors listed on Bioxyne.

NameTitleAgeTotal Pay
Mr. Nam Hoat Chua B.A., BAMD, CEO & Director180.43k
Mr. Guy Adrian Robertson B.Com., B.Comm(Hons.), C.A., CA, MAICDCFO & Company Sec.80k

Profitability and management effectiveness

Profit margin

-22.49%

Operating margin

-6.79%

Return on assets

-3.11%

Return on equity

-21.82%

Profitability ratios are a class of financial metrics that are used to assess a business's ability to generate earnings relative to its revenue, operating costs, balance sheet assets, and shareholders' equity over time, using data from a specific point in time.

The return on equity signifies how well the management is running the company in terms of capital management. The ideal return on equity is greater than 10%. The return on equity is calculated as net income divided by total share holders equity.

Valuation and Trading Info

The market capitalization of Bioxyne is and its enterprise value is .

The BXN's stocks Beta value is 1.25 making it 25% more volatile compared to ASX market index. Technology stocks and small caps tend to have higher betas than the market benchmark. This indicates that adding the stock to a portfolio will increase the portfolio’s risk, but also increase its expected return. On the other hand utility stocks often have low betas because they tend to move more slowly than market averages.

Companies similar to Bioxyne (BXN)

Bioxyne (ASX:BXN) Frequently Asked Questions

1. What is Bioxyne's Stock Symbol?

Bioxyne trades on ASX under the ticker symbol "BXN".

2. What is Bioxyne's stock price today?

One share of BXN stock can currently be purchased for approximately $0.025.

3. How can I contact Bioxyne?

Bioxyne's mailing address is 50 Clarence Street Suite 506 Level 5 Sydney NSW 2000 Australia. The company can be reached via phone at 61 2 9078 8180.

4. What is Bioxyne's official website?

The official website of Bioxyne is https://www.bioxyne.com.

5. Which share registry manages Bioxyne's stock?

Bioxyne's stock is managed by AUTOMIC REGISTRY SERVICES.